🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsRybelsus 14mg real-world experience thread — anyone have experience? Page 3

Rybelsus 14mg real-world experience thread — anyone have experience?

wendy_avl Wed, Apr 1, 2026 at 7:40 AM 33 replies 1,177 viewsPage 3 of 7
JennaRN
Senior Member
1,987
8,923
Mar 2024
Colorado
Online
Apr 6, 2026 at 3:17 PM#11
SleepDoc_PDX said:
Relative and absolute effects need reading together.

Agreed, and subgroup analyses deserve particular suspicion. With enough subgroups something is significant by chance, and pre-registered subgroups are a different animal from ones found afterwards.

50 23Dr.KarenChen, Dr.NateNeph, PharmD_Rodriguez and 47 others
Reply Quote Save Share Report
A1cHero_PHX
Member
523
2,678
Jul 2024
Phoenix, AZ
Apr 6, 2026 at 10:19 PM#12
BethLabQueen said:
The absorption variability is real, but it partly averages out over weeks — the steady-state trough is less erratic than any single day would suggest.

This answered a question I did not know how to ask. I will report back once I have actually tried it.

1 24KarenAZ_mom
Reply Quote Save Share Report
sarah_nash92
Member
712
3,123
Jun 2024
Nashville, TN
Apr 7, 2026 at 5:21 AM#13
SleepDoc_PDX said:
Relative and absolute effects need reading together.

I read this differently from SleepDoc_PDX, on substance rather than tone. I would add the less popular caveat: these trial populations under-represented several groups, older adults and the highest BMI categories among them. The results probably generalise, and "probably" should be stated as an assumption rather than dropped.

2 0ZaraB_AL, JakeSmashed95
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
HPLC_Greg
Senior Member
1,890
8,901
Feb 2024
Research Triangle, NC
Apr 7, 2026 at 12:23 PM#14

One concrete data point for the thread. If you are going to change something, change one thing and give it long enough to express itself. Four weeks is the usual minimum for anything pharmacological on this board, and two weeks of data has told you almost nothing.

3 1Dr.MetabolicMD, RetaRick_CA, JenPlateau
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Apr 7, 2026 at 7:24 PM#15

Moderator note: leaving this open. It is being argued well and the disagreement is the useful part. No action needed from anybody.

4 2PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 1 other
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register